The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Acadia Pharmaceuticals Inc. ACAD reported fourth-quarter 2022 loss of 26 cents per share, wider than the Zacks Consensus Estimate of a loss of 25 cents. The loss was on par with our estimate of a loss ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Acadia Pharmaceuticals (ACAD) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2022. This widely-known consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results